Search alternatives:
stem decrease » step decrease (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
d decrease » a decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 1 - 20 results of 79,910 for search '(((( 59 ((nn decrease) OR (_ decrease)) ) OR ( a d decrease ))) OR ( _ stem decrease ))*', query time: 0.93s Refine Results
  1. 1
    Low oxygen decreased TAp63 and p63γ mRNA expression.

    Low oxygen decreased TAp63 and p63γ mRNA expression. by Kevin M. Curtis (718103)

    Published 2015
    Save to List
    Saved in:
  2. 2
    Targeted knockdown of p63γ variants decreased the mRNA expression of VDR, osterix, runx2 and osteopontin.

    Targeted knockdown of p63γ variants decreased the mRNA expression of VDR, osterix, runx2 and osteopontin. by Kevin M. Curtis (718103)

    Published 2015
    Save to List
    Saved in:
  3. 3
    MSCs decrease oligodendrocyte death.

    MSCs decrease oligodendrocyte death. by Justin D. Glenn (800439)

    Published 2015
    Save to List
    Saved in:
  4. 4
    MBCD decreased stemness in MDA-MB-231.

    MBCD decreased stemness in MDA-MB-231. by Ankit Sharma (578833)

    Published 2019
    “…(<b>E</b>) RT-PCR analysis was performed using total RNA and gene specific primers. Decreased levels of stemness markers CD44 and BMI1 were found in MBCD treated cells. …”
    Save to List
    Saved in:
  5. 5
    Near anoxia decreases expression of stemness-related markers.

    Near anoxia decreases expression of stemness-related markers. by Rohini L. Kadle (4919335)

    Published 2018
    Save to List
    Saved in:
  6. 6
    Ifit2 deficiency results in decreased neuroinflammation upon RSA59 infection.

    Ifit2 deficiency results in decreased neuroinflammation upon RSA59 infection. by Jayasri Das Sarma (652473)

    Published 2020
    Save to List
    Saved in:
  7. 7
    The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability.

    The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

    Published 2025
    Save to List
    Saved in:
  8. 8
    Targeting <i>A20</i> decreases glioma stem cell growth.

    Targeting <i>A20</i> decreases glioma stem cell growth. by Anita B. Hjelmeland (104655)

    Published 2010
    “…Tubulin expression demonstrates equivalent protein loading. (C and D) Cell counts with Trypan Blue staining demonstrates that decreasing expression of A20 reduces the growth of glioma stem cells isolated from T4121 (C) or T08-836 (D) patient specimens passaged short term in immunocompromised mice. …”
    Save to List
    Saved in:
  9. 9
    Targeting <i>A20</i> decreases glioma stem cell survival.

    Targeting <i>A20</i> decreases glioma stem cell survival. by Anita B. Hjelmeland (104655)

    Published 2010
    “…<p>(A) Annexin V staining demonstrates increased apoptosis with <i>A20</i> targeting in glioma stem cells isolated from a D317 glioma xenograft or a T3359 patient specimen passaged short term in immunocompromised mice. …”
    Save to List
    Saved in:
  10. 10
    KLF4 knockdown decreased the population of cancer stem cells and cell migration in A431 cells.

    KLF4 knockdown decreased the population of cancer stem cells and cell migration in A431 cells. by Juan Li (146180)

    Published 2012
    Save to List
    Saved in:
  11. 11
    A decrease in CD44+ cells in response to hypoxia.

    A decrease in CD44+ cells in response to hypoxia. by Daniel V. Brown (3797809)

    Published 2017
    Save to List
    Saved in:
  12. 12
    Significant decrease of SMAD4 protein in DBA iPSCs.

    Significant decrease of SMAD4 protein in DBA iPSCs. by Jingping Ge (636557)

    Published 2015
    “…A) Slight decrease of mRNA level of <i>SMAD4</i> in the DBA iPSCs with <i>RPS19</i> or <i>RPL5</i> mutations. …”
    Save to List
    Saved in:
  13. 13
    Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs.

    Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs. by Jingping Ge (636557)

    Published 2015
    “…The nuclear p-SMAD2 decreased in <i>RPL5</i> mutant and corrected lines. …”
    Save to List
    Saved in:
  14. 14
    Stable overexpression of <b>Δ</b>Np63α and <b>Δ</b>Np63γ increased the mRNA expression of osteocalcin and osterix, and decreased VDR.

    Stable overexpression of <b>Δ</b>Np63α and <b>Δ</b>Np63γ increased the mRNA expression of osteocalcin and osterix, and decreased VDR. by Kevin M. Curtis (718103)

    Published 2015
    Save to List
    Saved in:
  15. 15
    Prolonged treatment with propofol does not decrease the neural stem cell pool.

    Prolonged treatment with propofol does not decrease the neural stem cell pool. by Arvind Palanisamy (3159156)

    Published 2016
    Save to List
    Saved in:
  16. 16
    Prolonged treatment with oxytocin does not decrease the neural stem cell pool.

    Prolonged treatment with oxytocin does not decrease the neural stem cell pool. by Arvind Palanisamy (3159156)

    Published 2018
    Save to List
    Saved in:
  17. 17
    Targeting <em>A20</em> Decreases Glioma Stem Cell Survival and Tumor Growth

    Targeting <em>A20</em> Decreases Glioma Stem Cell Survival and Tumor Growth by Anita B. Hjelmeland (104655)

    Published 2010
    “…Inhibiting A20 expression decreased GSC growth and survival through mechanisms associated with decreased cell-cycle progression and decreased phosphorylation of p65/RelA. …”
    Save to List
    Saved in:
  18. 18
    BCL2A1a Over-Expression in Murine Hematopoietic Stem and Progenitor Cells Decreases Apoptosis and Results in Hematopoietic Transformation

    BCL2A1a Over-Expression in Murine Hematopoietic Stem and Progenitor Cells Decreases Apoptosis and Results in Hematopoietic Transformation by Jean-Yves Métais (127800)

    Published 2012
    Save to List
    Saved in:
  19. 19
    Supplementary Figures 1-8 from Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency

    Supplementary Figures 1-8 from Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency by Wan-Ching Yen (11520727)

    Published 2023
    Save to List
    Saved in:
  20. 20
    <i>SOX2</i> knockdown decreases OSCC cell migration and EMT.

    <i>SOX2</i> knockdown decreases OSCC cell migration and EMT. by Alessandro Sacco (8799386)

    Published 2023
    Save to List
    Saved in:

Search Tools: